How Does a Glitch in Genome Folding Lead to Disease?
The sequence of bases (As, Cs, Gs, and Ts) that make up our DNA matters: it is what determines our genetic blueprint, which in turn determines...
42 Results
Clear Filters
Dr. Maria Lehtinen Elucidates the Genetics Behind Brain and Speech Development
In a new study published in Neuron, a team from Boston Children’s Hospital led by NYSCF – Robertson Neuroscience Investigator Maria Lehtinen, PhD, discovered that a...
How Can Stem Cells Help Us Understand Rare Disease?
In a new article from the patient advocacy and research nonprofit Jordan’s Guardian Angels, NYSCF speaks about its work creating induced pluripotent stem cells from patients with Jordan’s...
NYSCF Partners with ToolGen, nSAGE to Integrate Gene Editing and Stem Cell Technologies
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Dr. Feng Zhang Receives Grant From G. Harold and Leila Y. Mathers Foundation
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at the Broad Institute of MIT and Harvard and Professor of Brain and Cognitive Sciences and Biological Engineering at...
SPRITE: A New Technique For Mapping DNA In Our Nuclei
Researchers at the California Institute of Technology led by NYSCF – Robertson Investigator Mitchell Guttman, PhD, have developed a new tool called SPRITE to uncover how...
Four NYSCF Innovators Named 2018 Howard Hughes Medical Institute Investigators
This week, NYSCF – Robertson Investigators Feng Zhang, PhD (MIT), Ed Boyden, PhD (MIT), Gaby Maimon, PhD (The Rockefeller University), and Zachary Knight, PhD (University of...
NYSCF – Robertson Investigator Feng Zhang Launches “Beam Therapeutics”
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at Broad Institute of MIT and Harvard, Professor at Massachusetts Institute of Technology, along with David Liu, PhD, Professor...
NYSCF – Robertson Investigator Elected To European Molecular Biology Organization
NYSCF – Robertson Stem Cell Investigator Alexander Meissner, PhD, of the Max Planck Institute for Molecular Genetics was one of 62 scientists recently inducted into the...
NYSCF – Robertson Investigator Feng Zhang Featured On 60 Minutes
NYSCF — Robertson Investigator and MIT professor Feng Zhang, PhD, was interviewed on CBS’s 60 Minutes about CRISPR, the gene editing technology he helped pioneer that...
NYSCF Investigator Looks To Animal Genomes To Learn More About Human Disease
Elephants don’t get cancer. Well, they do, but not nearly at the same rate as other mammals. In a way, this is odd because cancer is...
CRISPR Gets A New Skill: Diagnosing Disease
CRISPR is everywhere. There’s so much work being done with this revolutionary gene-editing tool that it warrants its own journal. And researchers are still finding new...
The Adventures of Pioneer Factors
The DNA in each of our cells is identical, but not every cell expresses it in the same way. Genes are expressed in different ways at...
Unraveling The Mystery Of Our Scrunched-Up DNA
A group of researchers at the University of Pennsylvania led by NYSCF — Robertson Investigator Jennifer Phillips-Cremins, PhD, have developed a tool to examine why the physical...
2017 Year in Review
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
NYSCF Innovator Improves CRISPR Genome Repair
CRISPR is a revolutionary gene-editing technology that has many potential applications in medicine. Derrick Rossi, PhD, Associate Professor at Harvard University and NYSCF – Robertson Investigator...
New CRISPR Target: RNA
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize recipient Feng Zhang, PhD, Core Member of the Broad Institute of Harvard and...
CRISPR Gene Editing Technology Enables Novel RNA Research
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang and his team at the Broad Institute of Harvard...
NYSCF Innovator Uses Gene Editing Technology to Screen Deadly Brain Cancer for Weaknesses
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang and his team at the Broad Institute of Harvard and MIT...
NYSCF Innovator Feng Zhang Investigates the Role of Genetic Diversity in Future Gene Editing Treatments
The possibilities and implications of utilizing gene editing technology to treat patients raise thorny questions that must be addressed in a careful and thorough research and...
NYSCF Innovator Describes Potential Cell Replacement Strategy for Parkinson’s Disease
The traditional cell replacement therapy model relies on manufacturing the relevant cell type in the lab and injecting or replacing these cells into the patient, curing...
Five Women Unite to Crack the Code of Multiple Sclerosis
In a collaborative tour de force, five female principal investigators, including NYSCF’s own Dr. Valentina Fossati, are uncovering the cellular mechanisms behind multiple sclerosis (MS). Over...
New Tools for Simultaneous, Multi-Gene Editing
NYSCF – Robertson Stem Cell Investigator and NYSCF – Robertson Stem Cell Prize Awardee Dr. Feng Zhang, the Broad Institute of Harvard and MIT, published his latest...
Feng Zhang Receives 2016 NYSCF – Robertson Stem Cell Prize
NYSCF announced today that Feng Zhang, PhD, is the 2016 recipient of the NYSCF – Robertson Stem Cell Prize for his pioneering advances to edit human...
Partnering to Accelerate Alzheimer’s Research
The NYSCF Research Institute is committed to accelerating research by sharing its expertise and leveraging its technologies with scientists at collaborating institutions around the world. A...